Skip to Content

M 228 (Pioglitazone hydrochloride 30 mg (base))

Pill imprint M 228 has been identified as Pioglitazone hydrochloride 30 mg (base).

Pioglitazone is used in the treatment of nonalcoholic fatty liver disease; diabetes, type 2 and belongs to the drug class thiazolidinediones. Risk cannot be ruled out during pregnancy. Pioglitazone 30 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).

Pioglitazone hydrochloride 30 mg (base) M 228  Front
Pioglitazone hydrochloride 30 mg (base) M 228  Back
Pioglitazone hydrochloride 30 mg (base) M 228
Discount Card Promo
Pioglitazone hydrochloride
M 228
30 mg (base)
Prescription only
Drug Class:
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
Inactive Ingredients:
hydroxypropyl cellulose
lactose monohydrate
magnesium stearate
sodium lauryl sulfate
sodium starch glycolate type A potato
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0514 UDL Laboratories Inc

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.